Shineco Inc. has announced the acquisition of a controlling 51% stake in Xi'an Dong'ao Health Management Co., Ltd., a company specializing in cryogenic cell storage and clinical applications. This strategic acquisition supports Shineco's initiative to operationalize the tokenization of biological cellular assets by providing the necessary off-chain infrastructure for token redemption. This move, combined with their prior acquisition of Singapore-based Infiniclone, strengthens Shineco's global storage and infusion network, ensuring seamless on-chain and off-chain asset settlement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shineco Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN54480) on August 20, 2025, and is solely responsible for the information contained therein.